Skip to main content

Trans-Activating Transcriptional Activator (TAT) Peptide-Mediated Brain Drug Delivery

Buy Article:

$113.00 plus tax (Refund Policy)

A review of several studies that involve the use of Trans-activating transcriptional activator (TAT) peptide as a drug delivery molecule is presented. Briefly, we discuss the biology of the peptide with regards to its cellular entry, the use of TAT in targeting various cell organelles for drug delivery, and its cytotoxicity. Significant attention is given to works in which the peptide was specifically used as a carrier for drugs used in the treatment of various neurological disorders such as the CNS infections, Alzheimer's disease and Parkinson's disease. We conclude by discussing the potential applications of TAT peptide as a carrier molecule for drug delivery vehicles such as liposomes and nanoparticles.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Data/Media
No Metrics


Document Type: Review Article

Publication date: 2006-10-01

More about this publication?
  • Journal of Biomedical Nanotechnology (JBN) is a peer-reviewed multidisciplinary journal providing broad coverage in all research areas focused on the applications of nanotechnology in medicine, drug delivery systems, infectious disease, biomedical sciences, biotechnology, and all other related fields of life sciences.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Terms & Conditions
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more